{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:31:13Z","timestamp":1794270673543,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Taizhou Municipal Bureau of Science and Technology","award":["1901ky43"],"award-info":[{"award-number":["1901ky43"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85716-6","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:42:39Z","timestamp":1736404959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["RNF138 contributes to cisplatin resistance in nasopharyngeal carcinoma cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Hangyu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"85716_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3892\/etm.2021.11059","volume":"23","author":"D Jicman Stan","year":"2022","unstructured":"Jicman Stan, D. et al. Nasopharyngeal carcinoma: a new synthesis of literature data (review). Exp. Ther. Med. 23, 136. https:\/\/doi.org\/10.3892\/etm.2021.11059 (2022).","journal-title":"Exp. Ther. Med."},{"key":"85716_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.14639\/0392-100X-N2222","volume":"43","author":"G Cantu","year":"2023","unstructured":"Cantu, G. Nasopharyngeal carcinoma. A different head and neck tumour. Part A: from histology to staging. Acta Otorhinolaryngol. Ital. 43, 85\u201398. https:\/\/doi.org\/10.14639\/0392-100X-N2222 (2023).","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"85716_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.6004\/jnccn.2022.0016","volume":"20","author":"JJ Caudell","year":"2022","unstructured":"Caudell, J. J. et al. NCCN Guidelines(R) insights: Head and Neck cancers, Version 1.2022. J. Natl. Compr. Canc Netw. 20, 224\u2013234. https:\/\/doi.org\/10.6004\/jnccn.2022.0016 (2022).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"85716_CR4","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/CMAR.S341472","volume":"14","author":"R Jiromaru","year":"2022","unstructured":"Jiromaru, R., Nakagawa, T. & Yasumatsu, R. Advanced Nasopharyngeal Carcinoma: current and emerging treatment options. Cancer Manag Res. 14, 2681\u20132689. https:\/\/doi.org\/10.2147\/CMAR.S341472 (2022).","journal-title":"Cancer Manag Res."},{"key":"85716_CR5","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-16145-4","author":"CW Jen","year":"2024","unstructured":"Jen, C. W. et al. Evaluating the efficacy of different treatment intensities in nasopharyngeal carcinoma patients: a Nationwide Cancer Registry-based study. Ann. Surg. Oncol. https:\/\/doi.org\/10.1245\/s10434-024-16145-4 (2024).","journal-title":"Ann. Surg. Oncol."},{"key":"85716_CR6","doi-asserted-by":"publisher","unstructured":"Peng, Z. et al. Treatment of recurrent nasopharyngeal carcinoma: a sequential challenge. Cancers (Basel). 14. https:\/\/doi.org\/10.3390\/cancers14174111 (2022).","DOI":"10.3390\/cancers14174111"},{"key":"85716_CR7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s11864-023-01101-3","volume":"24","author":"JJ Juarez-Vignon Whaley","year":"2023","unstructured":"Juarez-Vignon Whaley, J. J. et al. Recurrent\/Metastatic nasopharyngeal carcinoma treatment from Present to Future: where are we and where are we heading? Curr. Treat. Options Oncol. 24, 1138\u20131166. https:\/\/doi.org\/10.1007\/s11864-023-01101-3 (2023).","journal-title":"Curr. Treat. Options Oncol."},{"key":"85716_CR8","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2147\/OTT.S188148","volume":"12","author":"F Perri","year":"2019","unstructured":"Perri, F. et al. Management of recurrent nasopharyngeal carcinoma: current perspectives. Onco Targets Ther. 12, 1583\u20131591. https:\/\/doi.org\/10.2147\/OTT.S188148 (2019).","journal-title":"Onco Targets Ther."},{"key":"85716_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s43556-021-00043-2","volume":"2","author":"Q Yang","year":"2021","unstructured":"Yang, Q., Zhao, J., Chen, D. & Wang, Y. E3 ubiquitin ligases: styles, structures and functions. Mol. Biomed. 2, 23. https:\/\/doi.org\/10.1186\/s43556-021-00043-2 (2021).","journal-title":"Mol. Biomed."},{"key":"85716_CR10","doi-asserted-by":"publisher","first-page":"645864","DOI":"10.3389\/fphar.2021.645864","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu, Y., Duan, C. & Zhang, C. E3 ubiquitin ligase in Anticancer Drugdsla Resistance: recent advances and future potential. Front. Pharmacol. 12, 645864. https:\/\/doi.org\/10.3389\/fphar.2021.645864 (2021).","journal-title":"Front. Pharmacol."},{"key":"85716_CR11","doi-asserted-by":"publisher","first-page":"e1204","DOI":"10.1002\/ctm2.1204","volume":"13","author":"C Sampson","year":"2023","unstructured":"Sampson, C. et al. The roles of E3 ubiquitin ligases in cancer progression and targeted therapy. Clin. Transl Med. 13, e1204. https:\/\/doi.org\/10.1002\/ctm2.1204 (2023).","journal-title":"Clin. Transl Med."},{"key":"85716_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4155\/fmc-2021-0157","volume":"14","author":"KM Saravanan","year":"2022","unstructured":"Saravanan, K. M., Kannan, M., Meera, P., Bharathkumar, N. & Anand, T. E3 ligases: a potential multi-drug target for different types of cancers and neurological disorders. Future Med. Chem. 14, 187\u2013201. https:\/\/doi.org\/10.4155\/fmc-2021-0157 (2022).","journal-title":"Future Med. Chem."},{"key":"85716_CR13","doi-asserted-by":"publisher","unstructured":"Ye, P. et al. Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges. Cells 10, (2021). https:\/\/doi.org\/10.3390\/cells10123309","DOI":"10.3390\/cells10123309"},{"key":"85716_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/cbin.11423","volume":"45","author":"C Wu","year":"2021","unstructured":"Wu, C., Chen, L., Tao, H., Kong, L. & Hu, Y. RING finger protein 38 induces the drug resistance of cisplatin in non-small-cell lung cancer. Cell. Biol. Int. 45, 287\u2013294. https:\/\/doi.org\/10.1002\/cbin.11423 (2021).","journal-title":"Cell. Biol. Int."},{"key":"85716_CR15","doi-asserted-by":"publisher","unstructured":"Cruz, L., Soares, P. & Correia, M. Ubiquitin-specific proteases: players in Cancer Cellular processes. Pharmaceuticals (Basel). 14 https:\/\/doi.org\/10.3390\/ph14090848 (2021).","DOI":"10.3390\/ph14090848"},{"key":"85716_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41392-022-01152-2","volume":"7","author":"C Cai","year":"2022","unstructured":"Cai, C., Tang, Y. D., Zhai, J. & Zheng, C. The RING finger protein family in health and disease. Signal. Transduct. Target. Ther. 7, 300. https:\/\/doi.org\/10.1038\/s41392-022-01152-2 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"85716_CR17","doi-asserted-by":"publisher","unstructured":"Zeng, X. et al. RNF138 downregulates antiviral innate immunity by inhibiting IRF3 activation. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms242216110 (2023).","DOI":"10.3390\/ijms242216110"},{"key":"85716_CR18","doi-asserted-by":"publisher","unstructured":"Wu, H. et al. [Corrigendum] downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway. Oncol. Rep. 48 https:\/\/doi.org\/10.3892\/or.2022.8337 (2022).","DOI":"10.3892\/or.2022.8337"},{"key":"85716_CR19","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.1038\/emm.2017.247","volume":"50","author":"W Kim","year":"2018","unstructured":"Kim, W. et al. RNF138-mediated ubiquitination of rpS3 is required for resistance of glioblastoma cells to radiation-induced apoptosis. Exp. Mol. Med. 50, e434. https:\/\/doi.org\/10.1038\/emm.2017.247 (2018).","journal-title":"Exp. Mol. Med."},{"key":"85716_CR20","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1080\/15384047.2018.1480293","volume":"19","author":"Y Lu","year":"2018","unstructured":"Lu, Y. et al. RNF138 confers cisplatin resistance in gastric cancer cells via activating Chk1 signaling pathway. Cancer Biol. Ther. 19, 1128\u20131138. https:\/\/doi.org\/10.1080\/15384047.2018.1480293 (2018).","journal-title":"Cancer Biol. Ther."},{"key":"85716_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/jnci\/djaa100","volume":"113","author":"Y Lei","year":"2021","unstructured":"Lei, Y. et al. A gene-expression predictor for efficacy of induction chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma. J. Natl. Cancer Inst. 113, 471\u2013480. https:\/\/doi.org\/10.1093\/jnci\/djaa100 (2021).","journal-title":"J. Natl. Cancer Inst."},{"key":"85716_CR22","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1002\/imt2.107","volume":"2","author":"S Chen","year":"2023","unstructured":"Chen, S. Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp. Imeta 2, e107. https:\/\/doi.org\/10.1002\/imt2.107 (2023).","journal-title":"Imeta"},{"key":"85716_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods. 12, 357\u2013360. https:\/\/doi.org\/10.1038\/nmeth.3317 (2015).","journal-title":"Nat. Methods"},{"key":"85716_CR24","doi-asserted-by":"publisher","first-page":"e1009730","DOI":"10.1371\/journal.pcbi.1009730","volume":"18","author":"A Shumate","year":"2022","unstructured":"Shumate, A., Wong, B., Pertea, G. & Pertea, M. Improved transcriptome assembly using a hybrid of long and short reads with StringTie. PLoS Comput. Biol. 18, e1009730. https:\/\/doi.org\/10.1371\/journal.pcbi.1009730 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"85716_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"85716_CR26","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"85716_CR27","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592. https:\/\/doi.org\/10.1093\/nar\/gkac963 (2023).","journal-title":"Nucleic Acids Res."},{"key":"85716_CR28","doi-asserted-by":"publisher","first-page":"W317","DOI":"10.1093\/nar\/gkab447","volume":"49","author":"D Bu","year":"2021","unstructured":"Bu, D. et al. KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis. Nucleic Acids Res. 49, W317\u2013W325. https:\/\/doi.org\/10.1093\/nar\/gkab447 (2021).","journal-title":"Nucleic Acids Res."},{"key":"85716_CR29","doi-asserted-by":"publisher","unstructured":"Hung, S. H., Yang, T. H., Cheng, Y. F., Chen, C. S. & Lin, H. C. Association of Nasopharynx Cancer with Human Papillomavirus infections. Cancers (Basel). 15. https:\/\/doi.org\/10.3390\/cancers15164082 (2023).","DOI":"10.3390\/cancers15164082"},{"key":"85716_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.gene.2019.05.058","volume":"710","author":"P Zhang","year":"2019","unstructured":"Zhang, P. et al. Mir-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K\/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells. Gene 710, 103\u2013113. https:\/\/doi.org\/10.1016\/j.gene.2019.05.058 (2019).","journal-title":"Gene"},{"key":"85716_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.32604\/or.2022.025323","volume":"29","author":"ZN Navaei","year":"2021","unstructured":"Navaei, Z. N., Khalili-Tanha, G., Zangouei, A. S., Abbaszadegan, M. R. & Moghbeli, M. PI3K\/AKT signaling pathway as a critical regulator of cisplatin response in tumor cells. Oncol. Res. 29, 235\u2013250. https:\/\/doi.org\/10.32604\/or.2022.025323 (2021).","journal-title":"Oncol. Res."},{"key":"85716_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2020.10.051","volume":"498","author":"LX Peng","year":"2021","unstructured":"Peng, L. X. et al. LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3\/EGFR-ERK signaling resulting in unfavorable patient survival. Cancer Lett. 498, 165\u2013177. https:\/\/doi.org\/10.1016\/j.canlet.2020.10.051 (2021).","journal-title":"Cancer Lett."},{"key":"85716_CR33","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1158\/1055-9965.EPI-20-1702","volume":"30","author":"ET Chang","year":"2021","unstructured":"Chang, E. T., Ye, W., Zeng, Y. X. & Adami, H. O. The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev. 30, 1035\u20131047. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-1702 (2021).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"85716_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"85716_CR35","doi-asserted-by":"publisher","first-page":"635737","DOI":"10.3389\/fonc.2021.635737","volume":"11","author":"Z Liu","year":"2021","unstructured":"Liu, Z., Chen, Y., Su, Y., Hu, X. & Peng, X. Nasopharyngeal carcinoma: clinical achievements and considerations among Treatment options. Front. Oncol. 11, 635737. https:\/\/doi.org\/10.3389\/fonc.2021.635737 (2021).","journal-title":"Front. Oncol."},{"key":"85716_CR36","doi-asserted-by":"publisher","unstructured":"Liu, J. et al. Deubiquitinases in cancers: aspects of Proliferation, Metastasis, and apoptosis. Cancers (Basel). 14. https:\/\/doi.org\/10.3390\/cancers14143547 (2022).","DOI":"10.3390\/cancers14143547"},{"key":"85716_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cancergen.2020.12.002","volume":"252\u2013253","author":"LC de Almeida","year":"2021","unstructured":"de Almeida, L. C., Calil, F. A. & Machado-Neto, J. A. Costa-Lotufo, L. V. DNA damaging agents and DNA repair: from carcinogenesis to cancer therapy. Cancer Genet. 252\u2013253, 6\u201324. https:\/\/doi.org\/10.1016\/j.cancergen.2020.12.002 (2021).","journal-title":"Cancer Genet."},{"key":"85716_CR38","doi-asserted-by":"publisher","first-page":"zcad057","DOI":"10.1093\/narcan\/zcad057","volume":"5","author":"J Slyskova","year":"2023","unstructured":"Slyskova, J. et al. Detection of oxaliplatin- and cisplatin-DNA lesions requires different global genome repair mechanisms that affect their clinical efficacy. NAR Cancer. 5, zcad057. https:\/\/doi.org\/10.1093\/narcan\/zcad057 (2023).","journal-title":"NAR Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85716-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T07:06:47Z","timestamp":1736406407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85716-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85716"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85716-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethical Committee of Taizhou Central Hospital (Taizhou University Hospital) (approval number: 2019-54).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}}],"article-number":"1406"}}